DASH diet may lower the risk of cardiovascular disease in breast cancer survivors

FHS
April 17, 2024
10:51 am

A new paper in JNCI Cancer Spectrum, published by Oxford University Press, finds that following a healthy diet lowers the risk of cardiovascular disease in breast cancer survivors.

Insurance companies are forcing psychiatrists like me to stop accepting their coverage

“I’m sorry, but I’m unable to take on new patients at this time.” I’ve said that line hundreds of times in the 15 years since

January 4, 2024

Brenzavvy vs Farxiga for T2D; PFAS in Seafood; 100 Deaths Linked to GLP-1 Drugs?

Bexagliflozin (Brenzavvy) and dapagliflozin (Farxiga) induced similar HbA1c reductions over 24 weeks in a head-to-head phase III trial of the SGLT2 inhibitors in Chinese adults

April 17, 2024

Developing high-potent APIs: The necessary steps to follow – Pharmaceutical Technology

Rigorous measures need to be in place to protect clinical staff from toxic HPAPIs. Image credit: Gorodenkoff The demand for high-potency active pharmaceutical ingredients (HPAPIs)

August 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.